Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
High risk lapses in care in proliferative diabetic retinopathy: risk factors and outcomes analysis
Author Affiliations & Notes
  • Serina Applebaum
    Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States
  • Julia Jieyu Fu
    Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States
  • Kristen Harris Nwanyanwu
    Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, United States
  • Footnotes
    Commercial Relationships   Serina Applebaum None; Julia Fu None; Kristen Nwanyanwu None
  • Footnotes
    Support  This publication was made possible by Grant Number 1 K23 EY030530-01 from the National Eye Institute. This work has been supported in part by an unrestricted/challenge award to Yale Eye Center from the Research to Prevent Blindness (RPB), Inc.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1806. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Serina Applebaum, Julia Jieyu Fu, Kristen Harris Nwanyanwu; High risk lapses in care in proliferative diabetic retinopathy: risk factors and outcomes analysis. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1806.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The American Academy of Ophthalmology recommends close regular follow up for patients with proliferative diabetic retinopathy (PDR) in order to prevent vision loss. Understudied elements of retention in care include the duration and number of lapses, i.e. periods of loss to follow up followed by return to care. We identified risk factors for longer and more frequent lapses in care among individuals with PDR and assessed the relationship between high risk lapses and systemic and visual outcomes.

Methods : We performed a retrospective single-center chart abstraction of patients with PDR from 2012-2023. A lapse in care was defined as any interval ≥6 months between eye exams after diagnosis of PDR. We collected and used descriptive statistics to analyze demographic and socioeconomic factors, systemic comorbidities, and initial and final systemic and visual health. We used univariate and multivariable linear regression to assess these factors’ associations with duration of lapse and number of lapses per patient, as well as their associations with final outcomes.

Results : Of 882 total patients with PDR, 698 (79%) had a lapse in care during the study period. The average lapse duration [SD] was 357.5 [269] days and average number of lapses per patient was 2.7 [2.1]. In adjusted models, Black or African American (AA) race was associated with 46.3 days longer (p=0.02), but 0.42 fewer (p=0.006), lapses than White race. Individuals with Medicare insurance and better initial visual acuity in ETDRS letter score (VA) were more likely to have lapses in care (β=0.46, p=0.047; β=0.01, p=0.012). Among all patients, systolic blood pressure (SBP), hemoglobin A1C (HbA1C), and intraocular pressure (IOP) all significantly improved from initial to final visit (all p<0.001), while VA did not change. Medicaid insurance was associated with a 9.41 point worse final VA (p=0.01) than private insurance; undergoing dialysis was associated with lower final HbA1C (β=-0.85, p<0.001); and Black or AA race was associated with 5.61mmHg higher SBP than White race (p=0.03).

Conclusions : Black and AA patients are at risk for longer lapses in PDR eye care. More frequent or longer duration lapses in care were not associated with clinically significant different outcomes in our population. Further research may better elucidate the link between visit intervals and vision loss, which may impact follow-up recommendations.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×